Pronóstico del mercado europeo de inmunohistoquímica hasta 2028: impacto de COVID-19 y análisis regional por aplicación (diagnóstico y pruebas de fármacos), producto (anticuerpos, equipos, reactivos y kits) y usuario final (hospitales y laboratorios de diagnóstico, institutos de investigación y otros)

Introducción al mercado

Europa es el segundo mercado más grande para la inmunohistoquímica, seguido del Reino Unido, Alemania, Francia, Italia, España y el resto. de Europa son los principales contribuyentes a este mercado en esta región. Alemania lideró el mercado durante el período previsto. Alemania ha sido testigo de un tremendo aumento de casos de cáncer en los últimos años; por ejemplo, según el Observatorio Mundial del Cáncer, en 2020 se encontraron un total de 6.28.519 casos nuevos en ambos sexos y todas las edades, 69.697 (11,1%) casos de cáncer de mama, 67.959 (10,8%) Cáncer de próstata, 64.804 (10,3%) Cáncer de pulmón, 57.528 (9,2%) Cáncer colorrectal, 35.147 (5,6%) Cáncer de vejiga y 333.384 (53%) Otros cánceres. La inmunohistoquímica se utiliza ampliamente en el diagnóstico y tratamiento del cáncer; por tanto, la demanda de inmunohistoquímica está aumentando en el país. La prevalencia de enfermedades cardiovasculares está aumentando en el país. La población de edad avanzada contribuye en gran medida al aumento de la prevalencia de enfermedades cardiovasculares. Los cambios demográficos están creando grandes desafíos para la atención al paciente. El número de enfermedades crónicas también crece constantemente junto con una población cada vez más envejecida. Al mismo tiempo, está aumentando la presión de los costes en el sector sanitario. Como afirma el Instituto Max Planck de 2019, aproximadamente entre el 30 y el 40% de los adultos tienen presión arterial alta en el país. La incidencia aumenta con la edad y las personas mayores de 60 años tienen más probabilidades de desarrollar ECV. La IHC se está volviendo cada vez más popular en el campo del diagnóstico clínico porque se utiliza para diagnosticar enfermedades crónicas como el cáncer, enfermedades infecciosas, enfermedades cardiovasculares y enfermedades autoinmunes. Por lo tanto, se espera que la creciente prevalencia de enfermedades crónicas aumente la demanda de soluciones inmunohistoquímicas, promoviendo así el crecimiento del mercado.

Los países de Europa, especialmente Francia, se ven muy afectados debido al brote de COVID-19. Los anticuerpos de inmunohistoquímica contra el coronavirus son métodos inmunológicos que pueden usarse para identificar miembros de la familia Coronaviridae de virus de ARN que infectan a aves y mamíferos. A continuación se enumeran los anticuerpos contra antígenos expresados por varias cepas de coronavirus, como el SARS-CoV-2, el SARS-CoV, el MERS y otros patógenos no humanos como el coronavirus felino. Los objetivos comunes de los anticuerpos contra el coronavirus incluyen la nucleocápside (N) y la glicoproteína de pico (S). Estos anticuerpos están destinados a aplicaciones inmunohistoquímicas. El análisis de inmunohistoquímica muestra la detección de niveles de expresión diferencial de la nucleocápside del coronavirus SARS-CoV-2 y demuestra la especificidad de los anticuerpos. El análisis inmunohistoquímico de la NP del coronavirus del SARS-CoV-2 utilizando el anticuerpo monoclonal (B46F) de la NP del coronavirus del SARS/SARS-CoV-2 (n.º de catálogo MA1-7404) muestra una tinción significativa en los tejidos de pulmón y placenta humanos infectados con el SARS-CoV-2. en comparación con los tejidos de control sin SARS-CoV-2. Investigadores del Reino Unido y Suecia utilizaron recientemente inmunohistoquímica multiplexada extremadamente sensible para examinar la expresión de ACE2 en los pericitos cerebrales de pacientes con síntomas neurológicos en pacientes y controles con COVID-19. También utilizaron inmunofenotipado espacial para evaluar la inflamación en el tejido cerebral de los pacientes con COVID-19.

Descripción general y dinámica del mercado

El Se espera que el mercado europeo de inmunohistoquímica crezca de 631,33 millones de dólares en 2021 a 1.022,27 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 7,1% de 2021 a 2028. Las pruebas de diagnóstico tradicionales generalmente se realizaban en laboratorios con equipos costosos y con personal capacitado responsable de realizar las pruebas. Desde las últimas décadas, las pruebas de diagnóstico han progresado gradualmente desde el laboratorio central hacia los sitios de prueba, que están cerca de los pacientes. La creciente demanda de inmunohistoquímica, junto con la escasez de personal en los laboratorios de inmunología, ha creado la necesidad de automatización en inmunohistoquímica. La automatización en inmunohistoquímica (IHC) brinda la oportunidad de mejorar los niveles de sensibilidad, reproducibilidad, estandarización, además de ofrecer ventajas como reducción del tiempo de trabajo y ahorro de reactivos. La flexibilidad analítica es uno de los factores esenciales requeridos en los protocolos de inmunohistoquímica. La automatización de la IHQ contribuye decisivamente a estandarizar las técnicas inmunohistoquímicas. Además, también ayuda a simplificar los métodos manuales de 16 pasos a métodos de 5 pasos que ayudan a minimizar la cantidad de personal que trabaja. Además, la inmunohistoquímica automatizada garantiza una calidad y descarga constante de las tinciones y mejora la estandarización y optimización de las diferentes técnicas. Además, con resultados confiables y rápidos, la automatización puede proporcionar resultados de pruebas de diagnóstico a mayor velocidad, lo que acorta el período de hospitalización y genera ahorros de costos. Por lo tanto, es probable que se acepten los diversos beneficios que ofrece la automatización en inmunohistoquímica (IHC) y actúen como una de las tendencias predominantes en el mercado europeo en los próximos años.

Segmentos clave del mercado

En términos de producto, el segmento de anticuerpos representó la mayor participación del mercado europeo de inmunohistoquímica en 2020. En términos de aplicación, el segmento de diagnóstico tuvo una mayor participación de mercado de el mercado europeo de inmunohistoquímica en 2020. Además, el segmento de hospitales y laboratorios de diagnóstico tuvo una mayor participación del mercado europeo de inmunohistoquímica según el usuario final en 2020.

Principales fuentes y empresas Listadas

Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado europeo de inmunohistoquímica son sitios web de empresas, informes anuales, informes financieros, documentos gubernamentales nacionales y estadísticas. base de datos, entre otros. Las principales empresas que figuran en el informe son Abcam plc; Tecnologías Agilent, Inc.; Bio SB; LABORATORIOS BIO-RAD INC.; Tecnología de señalización celular, Inc.; Danaher; F. HOFFMANN-LA ROCHE LTD.; MERCK KGaA; PerkinElmer Inc.; y THERMO FISHER SCIENTIFIC INC.

Informe de razones para comprar

Comprender el panorama del mercado europeo de inmunohistoquímica e identificar los segmentos de mercado que tienen más probabilidades de garantizar un fuerte retorno
Manténgase a la vanguardia al comprender los cambios constantes panorama competitivo para el mercado europeo de inmunohistoquímica
Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el mercado europeo de inmunohistoquímica identificando segmentos de mercado con las ventas probables más prometedoras
Ayuda a tomar decisiones comerciales informadas desde una perspectiva perspicaz y análisis completo del desempeño del mercado de varios segmentos del mercado de inmunohistoquímica de Europa
Obtener pronóstico de ingresos de mercado para varios segmentos de 2021 a 2028 en la región de Europa.

Segmentación del mercado de inmunohistoquímica en Europa

Mercado europeo de inmunohistoquímica: por producto

Equipo
- Sistemas de tinción de portaobjetos
- Sistemas de microarrays de tejidos
- Sistemas de procesamiento de tejidos
- Escáneres de portaobjetos
- Otros equipos
Anticuerpos
- Anticuerpos primarios
- Anticuerpos secundarios
Reactivos
- Tinciones histológicas
- Reactivos de bloqueo y fijación
- Sustratos cromogénicos
- Reactivos de fijación
- Estabilizadores
- Disolventes orgánicos
- Enzimas proteolíticas
- Diluyentes
Kits

Mercado de inmunohistoquímica en Europa - Por aplicación

Diagnóstico
- Cáncer
- Enfermedades infecciosas
- Enfermedades autoinmunes
- Diabetes Mellitus
- Enfermedades Nefrológicas
- Otras
Pruebas de Medicamentos

Mercado europeo de inmunohistoquímica: Por usuario final

Hospitales y laboratorios de diagnóstico
Institutos de investigación
Otros

Mercado de inmunohistoquímica en Europa: por país

Mercado europeo de inmunohistoquímica: perfiles de empresas

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Immunohistochemistry Market – By Product

1.3.2 Europe Immunohistochemistry Market – By Application

1.3.3 Europe Immunohistochemistry Market – By End User

1.3.4 Europe Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidences of Chronic and Infectious Diseases

5.1.2 Growing R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Issues Related to Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Opportunities in Several Countries

5.4 Future Trends

5.4.1 Use of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – Europe Analysis

6.1 Europe Immunohistochemistry Market Revenue Forecast and Analysis

7. Europe Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 Europe Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. Europe Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. Europe Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 Europe Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. Europe Immunohistochemistry Market – Country Analysis

10.1 Europe: Immunohistochemistry Market Revenue and Forecasts to 2028

10.1.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.1.2.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.1.2.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.1.2.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.1.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.1.3.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.1.4 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.2.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.2.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.2.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.2.3.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.2.4 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.3 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.3.2.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.3.2.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.3.2.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.3.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.3.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.3.4 France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.4.2.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.4.2.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.4.2.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.4.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.4.3.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.4.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.5 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.5.2.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.5.2.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.5.2.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.5.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.5.3.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.5.4 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.6 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.6.2.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.6.2.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.6.2.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.6.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.6.3.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.6.4 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on Europe Immunohistochemistry Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 Cell Signaling Technology, Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 MERCK KGaA

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 PerkinElmer Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 THERMO FISHER SCIENTIFIC INC.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Abcam plc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 BIO-RAD LABORATORIES INC.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Danaher

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Bio SB

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 4. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 5. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 7. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 8. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 9. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 11. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 12. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 14. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 15. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 16. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 18. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 19. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 21. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 22. France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 23. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 25. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 26. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 28. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 29. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 30. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 31. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 32. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 33. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 34. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Application (USD Million)

Table 35. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Diagnostics (USD Million)

Table 36. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by End User (USD Million)

Table 37. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 38. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 39. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 40. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 41. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 42. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 43. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 44. Organic Developments Done By Companies

Table 45. Inorganic developments done by Companies

Table 46. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Immunohistochemistry Market Segmentation

Figure 2. Europe Immunohistochemistry Market Segmentation, By Country

Figure 3. Europe Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. The UK to Show Significant Growth During Forecast Period

Figure 6. Europe and PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to Europe Immunohistochemistry Market

Figure 8. Europe Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. Europe Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. Europe Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Europe Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. Europe Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. Europe Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Europe Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Europe Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. Europe Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Europe Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. Europe Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. Europe Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. Europe Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. Europe Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. Europe Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. Europe Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. Europe Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. Europe Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. Europe Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. Europe Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. Europe Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. Europe Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. Europe Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. Europe Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. Europe Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. Europe Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. Europe Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. Europe Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. Europe Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. Europe Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. Europe Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. Europe Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. Europe Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. Europe: Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 43. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. Germany Immunohistochemistry Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48. Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 49. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 50. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe immunohistochemistry market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample